Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
Findings from this trial may reshape how physicians perceive and prescribe testosterone-replacement therapy for middle-aged and older men with hypogonadism, with no substantial rise in major adverse cardiac events reported.
Cardiology June 29th 2023